Technical Analysis for FPRX - Five Prime Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 4.09 2.51% 0.10
FPRX closed up 2.51 percent on Monday, October 21, 2019, on 74 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical FPRX trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Spinning Top Other 0.00%
Wide Bands Range Expansion 0.00%
Wide Bands Range Expansion 2.51%
Calm After Storm Range Contraction 0.25%
Narrow Range Bar Range Contraction 0.25%
NR7 Range Contraction 0.25%
Wide Bands Range Expansion 0.25%
Calm After Storm Range Contraction 0.99%
Wide Bands Range Expansion 0.99%

Older signals for FPRX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes. The company's product candidates include FP-1039/GSK3052230, a protein therapeutic is in PhaseIb clinical trials for trapping and neutralizing cancer-promoting fibroblast growth factors (FGFs) involved in cancer cell proliferation and new blood vessel formation; FPA008, an antibody that inhibits colony stimulating factor-1 receptor; and FPA144 is an antibody for inhibiting FGF receptor 2b, as well as to treat patients with gastric cancer and potentially other solid tumors. It has collaboration and license agreements with GlaxoSmithKline LLC, Glaxo Group Limited, GSK-HGS, Pfizer Inc., and UCB Pharma S.A. The company was founded in 2001 and is headquartered in South San Francisco, California.
Biotechnology Cancer Life Sciences Solid Tumors Monoclonal Antibodies Tyrosine Kinase Receptors Pfizer Glaxosmithkline Gastric Cancer Inflammatory Disease
Is FPRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 13.97
52 Week Low 3.22
Average Volume 309,085
200-Day Moving Average 8.4085
50-Day Moving Average 5.0102
20-Day Moving Average 4.0835
10-Day Moving Average 4.084
Average True Range 0.3063
ADX 34.95
+DI 15.318
-DI 26.8608
Chandelier Exit (Long, 3 ATRs ) 4.5511
Chandelier Exit (Short, 3 ATRs ) 4.1389
Upper Bollinger Band 4.7362
Lower Bollinger Band 3.4308
Percent B (%b) 0.5
BandWidth 31.967675
MACD Line -0.2774
MACD Signal Line -0.3372
MACD Histogram 0.0597
Fundamentals Value
Market Cap 114.85 Million
Num Shares 28.1 Million
EPS -4.26
Price-to-Earnings (P/E) Ratio -0.96
Price-to-Sales 37.28
Price-to-Book 3.79
PEG Ratio 0.14
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.42
Resistance 3 (R3) 4.41 4.28 4.37
Resistance 2 (R2) 4.28 4.20 4.29 4.35
Resistance 1 (R1) 4.19 4.15 4.24 4.20 4.33
Pivot Point 4.06 4.06 4.09 4.07 4.06
Support 1 (S1) 3.97 3.98 4.02 3.98 3.85
Support 2 (S2) 3.84 3.93 3.85 3.83
Support 3 (S3) 3.75 3.84 3.82
Support 4 (S4) 3.76